Press ReleasesSeptember 30, 2022BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY ScreenRead
Press ReleasesJuly 8, 2022BillionToOne launches oncology liquid biopsy products for research use & announces clinical research collaboration with UCSDRead
Media CoverageMarch 30, 2022BillionToOne Closes $125M Series C Funding with Premier Global InvestorsRead
Media CoverageFebruary 17, 2022BillionToOne CEO Oguzhan Atay, PhD, named in Top 25 CEOs in Biotech of 2022 by the Healthcare Technology ReportRead
Media CoverageOctober 20, 2021BillionToOne’s Senior Vice President of Sales and Commercial Operations Named One of the Top 25 Women Leaders in Biotechnology of 2021Read